302 related articles for article (PubMed ID: 29359185)
21.
Schäffler H; Breitrück A
Front Microbiol; 2018; 9():646. PubMed ID: 29692762
[No Abstract] [Full Text] [Related]
22. The role of fungi in C. difficile infection: An underappreciated transkingdom interaction.
Stewart D; Romo JA; Lamendella R; Kumamoto CA
Fungal Genet Biol; 2019 Aug; 129():1-6. PubMed ID: 30978391
[TBL] [Abstract][Full Text] [Related]
23. Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections.
Lancaster JW; Matthews SJ
Clin Ther; 2012 Jan; 34(1):1-13. PubMed ID: 22284993
[TBL] [Abstract][Full Text] [Related]
24. Gut metabolites predict Clostridioides difficile recurrence.
Dawkins JJ; Allegretti JR; Gibson TE; McClure E; Delaney M; Bry L; Gerber GK
Microbiome; 2022 Jun; 10(1):87. PubMed ID: 35681218
[TBL] [Abstract][Full Text] [Related]
25. Differences of the Fecal Microflora With Clostridium difficile Therapies.
Louie TJ; Byrne B; Emery J; Ward L; Krulicki W; Nguyen D; Wu K; Cannon K
Clin Infect Dis; 2015 May; 60 Suppl 2():S91-7. PubMed ID: 25922407
[TBL] [Abstract][Full Text] [Related]
26. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.
Zhang L; Dong D; Jiang C; Li Z; Wang X; Peng Y
Anaerobe; 2015 Aug; 34():1-7. PubMed ID: 25817005
[TBL] [Abstract][Full Text] [Related]
27. Risk factors and intestinal microbiota: Clostridioides difficile infection in patients receiving enteral nutrition at Intensive Care Units.
Wang D; Dong D; Wang C; Cui Y; Jiang C; Ni Q; Su T; Wang G; Mao E; Peng Y
Crit Care; 2020 Jul; 24(1):426. PubMed ID: 32660525
[TBL] [Abstract][Full Text] [Related]
28. SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI.
Sattar A; Thommes P; Payne L; Warn P; Vickers RJ
J Antimicrob Chemother; 2015; 70(6):1757-62. PubMed ID: 25652749
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France.
Watt M; Dinh A; Le Monnier A; Tilleul P
J Med Econ; 2017 Jul; 20(7):678-686. PubMed ID: 28299963
[TBL] [Abstract][Full Text] [Related]
30. Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.
Polage CR; Gyorke CE; Kennedy MA; Leslie JL; Chin DL; Wang S; Nguyen HH; Huang B; Tang YW; Lee LW; Kim K; Taylor S; Romano PS; Panacek EA; Goodell PB; Solnick JV; Cohen SH
JAMA Intern Med; 2015 Nov; 175(11):1792-801. PubMed ID: 26348734
[TBL] [Abstract][Full Text] [Related]
31. Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection.
Miller M
Expert Opin Pharmacother; 2010 Jun; 11(9):1569-78. PubMed ID: 20446864
[TBL] [Abstract][Full Text] [Related]
32. Fidaxomicin for the treatment of Clostridium difficile infections.
Whitman CB; Czosnowski QA
Ann Pharmacother; 2012 Feb; 46(2):219-28. PubMed ID: 22318930
[TBL] [Abstract][Full Text] [Related]
33. Fidaxomicin--the new drug for Clostridium difficile infection.
Vaishnavi C
Indian J Med Res; 2015 Apr; 141(4):398-407. PubMed ID: 26112840
[TBL] [Abstract][Full Text] [Related]
34. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
35. Clostridium difficile colitis: review of the therapeutic approach.
Joseph J; Singhal S; Patel GM; Anand S
Am J Ther; 2014; 21(5):385-94. PubMed ID: 22990077
[TBL] [Abstract][Full Text] [Related]
36. Randomized clinical trial to evaluate the effect of fecal microbiota transplant for initial Clostridium difficile infection in intestinal microbiome.
Camacho-Ortiz A; Gutiérrez-Delgado EM; Garcia-Mazcorro JF; Mendoza-Olazarán S; Martínez-Meléndez A; Palau-Davila L; Baines SD; Maldonado-Garza H; Garza-González E
PLoS One; 2017; 12(12):e0189768. PubMed ID: 29261736
[TBL] [Abstract][Full Text] [Related]
37. A Diagnostic Algorithm for the Detection of Clostridium difficile-Associated Diarrhea.
Yoldaş Ö; Altındiş M; Cufalı D; Aşık G; Keşli R
Balkan Med J; 2016 Jan; 33(1):80-6. PubMed ID: 26966622
[TBL] [Abstract][Full Text] [Related]
38. Clostridium difficile infection: a review of current and emerging therapies.
Ofosu A
Ann Gastroenterol; 2016; 29(2):147-54. PubMed ID: 27065726
[TBL] [Abstract][Full Text] [Related]
39.
Chen See JR; Leister J; Wright JR; Kruse PI; Khedekar MV; Besch CE; Kumamoto CA; Madden GR; Stewart DB; Lamendella R
Front Microbiol; 2024; 15():1398018. PubMed ID: 38680911
[No Abstract] [Full Text] [Related]
40. Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing.
Shahinas D; Silverman M; Sittler T; Chiu C; Kim P; Allen-Vercoe E; Weese S; Wong A; Low DE; Pillai DR
mBio; 2012 Oct; 3(5):. PubMed ID: 23093385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]